Results 111 to 120 of about 1,180,576 (325)

Perspectives in educating molecular pathologists on liquid biopsy: Toward integrative, equitable, and decentralized precision oncology

open access: yesMolecular Oncology, EarlyView.
Liquid biopsy enables minimally invasive, real‐time molecular profiling through analysis of circulating biomarkers in biological fluids. This Perspective highlights the importance of training pathologists through integrative educational programs, such as the European Masters in Molecular Pathology, to ensure effective and equitable implementation of ...
Marius Ilié   +13 more
wiley   +1 more source

Description of verb aspect in grammars of the Kajkavian literary language

open access: yesRasprave Instituta za Hrvatski Jezik i Jezikoslovlje, 2008
In grammars of the Kajkavian literary language, verb aspect is described both implicitly and explicitly. I. Kristijanović’s grammar, in which the author described verb aspect as one of the basic characteristics of a verb, is an example of the explicit ...
Željka Brlobaš
doaj  

Potential therapeutic targeting of BKCa channels in glioblastoma treatment

open access: yesMolecular Oncology, EarlyView.
This review summarizes current insights into the role of BKCa and mitoBKCa channels in glioblastoma biology, their potential classification as oncochannels, and the emerging pharmacological strategies targeting these channels, emphasizing the translational challenges in developing BKCa‐directed therapies for glioblastoma treatment.
Kamila Maliszewska‐Olejniczak   +4 more
wiley   +1 more source

ABOUT EQUIVALENCE RELATIONS BETWEEN ‘ANTONYM’ PROVERBS IN CROATIAN AND GERMAN [PDF]

open access: yesHum, 2015
The subject of the paper is to determine interlingual equivalency relations between ‘antonym’ proverbs in Croatian and German. We recon on equivalency typology, elaborated by contrastive phraseology and typology of antonyms from the aspect of the ...
Senka Marinčić, Nikolina Pandža
doaj  

Developing evidence‐based, cost‐effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities

open access: yesMolecular Oncology, EarlyView.
The cancer problem is increasing globally with projections up to the year 2050 showing unfavourable outcomes in terms of incidence and cancer‐related deaths. The main challenges are prevention, improved therapeutics resulting in increased cure rates and enhanced health‐related quality of life.
Ulrik Ringborg   +43 more
wiley   +1 more source

PARP inhibition and pharmacological ascorbate demonstrate synergy in castration‐resistant prostate cancer

open access: yesMolecular Oncology, EarlyView.
Pharmacologic ascorbate (vitamin C) increases ROS, disrupts cellular metabolism, and induces DNA damage in CRPC cells. These effects sensitize tumors to PARP inhibition, producing synergistic growth suppression with olaparib in vitro and significantly delayed tumor progression in vivo. Pyruvate rescue confirms ROS‐dependent activity.
Nicolas Gordon   +13 more
wiley   +1 more source

The Role of Normalization in the Belief Propagation Algorithm [PDF]

open access: yes, 2011
An important part of problems in statistical physics and computer science can be expressed as the computation of marginal probabilities over a Markov Random Field.
Furtlehner, Cyril   +2 more
core   +3 more sources

Heavy Vector Triplets: Bridging Theory and Data

open access: yes, 2014
We introduce a model-independent strategy to study narrow resonances which we apply to a heavy vector triplet of the Standard Model (SM) group for illustration.
Pappadopulo, Duccio   +3 more
core   +1 more source

LDAcoop: Integrating non‐linear population dynamics into the analysis of clonogenic growth in vitro

open access: yesMolecular Oncology, EarlyView.
Limiting dilution assays (LDAs) quantify clonogenic growth by seeding serial dilutions of cells and scoring wells for colony formation. The fraction of negative wells is plotted against cells seeded and analyzed using the non‐linear modeling of LDAcoop.
Nikko Brix   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy